ESP vs Subcostal TAP Block for Analgesia After Laparoscopic Cholecystectomy
ESP TAP
Comparison Of Ultrasound-guided Erector Spinae Plane Block And Subcostal Transversus Abdominis Plane Block For Postoperative Analgesia In Laparoscopic Cholecystectomy: A Prospective Randomized Double-blind Multicenter Trial
1 other identifier
interventional
100
1 country
1
Brief Summary
This prospective, randomized, double-blind study compares the analgesic efficacy of ultrasound-guided erector spinae plane (ESP) block and subcostal transversus abdominis plane (TAP) block in patients undergoing laparoscopic cholecystectomy. The primary outcome is 24-hour postoperative opioid consumption. Secondary outcomes include postoperative pain scores, time to first analgesic request, shoulder pain, postoperative nausea and vomiting, and block-related complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2027
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 26, 2026
CompletedFirst Posted
Study publicly available on registry
June 22, 2026
CompletedStudy Start
First participant enrolled
June 15, 2027
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2027
Study Completion
Last participant's last visit for all outcomes
September 15, 2027
June 22, 2026
June 1, 2026
3 months
February 26, 2026
June 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total Opioid Consumption in the First 24 Hours Postoperatively
Total opioid consumption during the first 24 postoperative hours, converted to intravenous morphine equivalent dose (mg), recorded from patient-controlled analgesia devices and supplemental opioid administration.
Within 24 hours after surgery
Study Arms (2)
Erector Spinae Plane Block
EXPERIMENTALPatients in this arm will receive ultrasound-guided bilateral erector spinae plane block following induction of general anesthesia. A standardized volume and concentration of local anesthetic will be administered at the appropriate thoracic level. All patients will receive standardized intraoperative anesthesia and postoperative multimodal analgesia.
Subcostal TAP Block
EXPERIMENTALPatients in this arm will receive ultrasound-guided bilateral subcostal transversus abdominis plane block following induction of general anesthesia. A standardized volume and concentration of local anesthetic will be administered. All patients will receive standardized intraoperative anesthesia and postoperative multimodal analgesia.
Interventions
Ultrasound-guided bilateral erector spinae plane block will be performed after induction of general anesthesia. The block will be administered at the appropriate thoracic vertebral level using a standardized volume and concentration of local anesthetic deposited in the fascial plane deep to the erector spinae muscle. The procedure will be performed by experienced anesthesiologists under sterile conditions.
Ultrasound-guided bilateral subcostal transversus abdominis plane block will be performed after induction of general anesthesia. A standardized volume and concentration of local anesthetic will be injected into the fascial plane between the rectus abdominis and transversus abdominis muscles along the subcostal margin. The procedure will be performed by experienced anesthesiologists under sterile conditions.
Eligibility Criteria
You may qualify if:
- Adults aged 18 years and older
- Scheduled for elective laparoscopic cholecystectomy under general anesthesia
- American Society of Anesthesiologists (ASA) physical status I-III
- Ability to understand the study protocol and provide written informed consent -
You may not qualify if:
- Known allergy or contraindication to local anesthetic agents
- Coagulopathy or anticoagulant therapy contraindicating regional anesthesia
- Infection at the planned injection site
- Body mass index (BMI) \> 35 kg/m²
- Chronic opioid use or opioid dependence
- Chronic pain syndromes requiring regular analgesic treatment
- Severe hepatic, renal, or cardiac dysfunction
- Pregnancy or breastfeeding
- Inability to communicate or assess pain using the Numerical Rating Scale (NRS)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gaziantep City Hospital
Şahinbey, Gaziantep, 27060, Turkey (Türkiye)
Related Publications (1)
This study will generate individual participant data (IPD) related to postoperative analgesia, including opioid consumption, pain scores, and block-related complications. Data will be de-identified prior to sharing. Access to IPD will be available upon reasonable request to the corresponding author after publication of the main study results. Data requests will require a signed data use agreement, specifying the purpose of analysis and acknowledgment of original investigators. Supporting documentation, including study protocol and statistical analysis plan, will also be provided to researchers granted access.
BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bekir Suat Kürkçüoğlu
Gaziantep City Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Patients and postoperative outcome assessors will be blinded to group allocation. The regional block will be performed after induction of general anesthesia to maintain participant blinding. Postoperative pain assessments and data collection will be conducted by investigators who are unaware of the assigned intervention. The anesthesiologist performing the block will not be involved in postoperative outcome assessment.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- medical doctor
Study Record Dates
First Submitted
February 26, 2026
First Posted
June 22, 2026
Study Start (Estimated)
June 15, 2027
Primary Completion (Estimated)
September 1, 2027
Study Completion (Estimated)
September 15, 2027
Last Updated
June 22, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share